UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series A Redeemable Convertible Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2022		350,000
Beginning balance at Dec. 31, 2022		$ 19,924
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)		(350,000)
Conversion of Series A Redeemable Convertible Preferred Stock to common stock		$ (23,154)
Exercise of warrants	$ 129,494		$ 32		$ 129,462
Exercise of warrants (in shares)			31,506,849
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value		$ 3,230
Ending balance (in shares) at Dec. 31, 2023		0
Ending balance at Dec. 31, 2023		$ 0
Beginning balance (in shares) at Dec. 31, 2022			43,484,867
Beginning balance at Dec. 31, 2022	269,322		$ 43	$ (98,258)	663,284	$ (306,789)		$ 11,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income including noncontrolling interests in subsidiaries	68,930					67,060		1,870
Other comprehensive loss	0
Distributions to noncontrolling interests in subsidiaries	(1,390)							(1,390)
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	(3,230)				(3,230)
Dividend on Series A Redeemable Convertible Preferred Stock	(1,400)				(1,400)
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)			9,616,746
Conversion of Series A Redeemable Convertible Preferred Stock to common stock	36,033		$ 10		36,023
Stock options exercised (in shares)			67,500
Stock options exercised	235				235
Issuance of common stock from the Rights Offering, Shares			15,068,753
Issuance of common stock from the Rights Offering	79,111		$ 15		79,096
Issuance of common stock for vesting of restricted stock units (in shares)			327,684
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			(34,167)
Shares withheld related to net share settlement of share-based awards (in shares)			(142,759)
Shares withheld related to net share settlement of share-based awards	(614)				(614)
Compensation expense for share-based awards	3,297				3,297
Acquisition of Benchmark	9,821							9,821
Ending balance (in shares) at Dec. 31, 2023			99,895,473
Ending balance at Dec. 31, 2023	589,609		$ 100	(98,258)	906,153	(239,729)	$ 0	21,343
Ending balance (in shares) at Dec. 31, 2024		0
Ending balance at Dec. 31, 2024		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income including noncontrolling interests in subsidiaries	(34,698)					(36,057)		1,359
Other comprehensive loss	(1,180)						(1,180)
Contributions from noncontrolling interests in subsidiaries	15,250							15,250
Change in ownership percentage in subsidiary	0				158			(158)
Stock options exercised (in shares)			61,667
Stock options exercised	223				223
Issuance of common stock for vesting of restricted stock units (in shares)			657,515
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			20,081
Shares withheld related to net share settlement of share-based awards (in shares)			(227,376)
Shares withheld related to net share settlement of share-based awards	(1,092)				(1,092)
Compensation expense for share-based awards	4,795				4,795
Repurchase of common stock (in shares)			(4,358,361)
Repurchase of common stock	(20,288)		$ (4)	(20,284)
Ending balance (in shares) at Dec. 31, 2024			96,048,999
Ending balance at Dec. 31, 2024	$ 552,619		$ 96	$ (118,542)	$ 910,237	$ (275,786)	$ (1,180)	$ 37,794